Sticky Banner
EN
VN

DrAid™ x Ferrum with mission of helping 7M patients

July 27, 2022
Author: admin

Ferrum Health, the industry leader in enterprise AI solutions for global health systems, announces that VinBrain’s DrAid™ Teleradiology solution is immediately available on the Ferrum AI Hub platform. DrAid leverages AI in radiology to support healthcare professionals in detecting abnormalities on chest x-rays.

 

Preventable medical errors affect up to 7 million patients and cost over $20 billion annually, but the cost is more than just financial. Medical errors compromise patient care and can lead to poor patient outcomes and even death. 

 

Errors of omission, or diagnostic errors, are a significant challenge in today’s healthcare environment. Staffing shortages, fatigue, time pressures, and clinical skill level can all play a role. A recent European study highlights that of the 1 billion imaging exams completed worldwide each year, at least 40 million include errors.

Pelu Tran, CEO and Co-Founder of Ferrum Health

Tweet

With the addition of DrAid, Ferrum’s AI platform expands the clinical tools available to health systems, enabling AI support across the patient journey. DrAid detects abnormalities on chest x-rays, adding a second read for lung nodules and pneumothorax.

 

“I feel grateful for the opportunity to work with Ferrum Health, to bring a bigger impact to the healthcare community. We look forward to our long-term partnership on this journey to solve humanity’s problems together,” said Steven Quoc Hung Truong, VinBrain CEO. “With each VinBrain product, we aim to help people and improve their quality of life through digital health with AI at the core.”

 

A long-term association with Ferrum and with the mission of "improving people's lives with the power of AI and IoT", DrAid promises to be one of the global health solutions and contributes to improving the quality of life for millions of people around the world.

Read Next
Latest News

Top

Stay up-to-date with the latest news and updates from VinBrain by subscribing to our newsletter!

Share